CG Oncology (NASDAQ:CGON) Price Target Raised to $68.00
CG Oncology (NASDAQ:CGON – Free Report) had its price objective increased by Royal Bank of Canada from $66.00 to $68.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has an outperform rating on the stock. Several other analysts also recently weighed in on the company. Cantor Fitzgerald reiterated an “overweight” […]
CG Oncology (NASDAQ:CGON – Free Report) had its price objective increased by Royal Bank of Canada from $66.00 to $68.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has an outperform rating on the stock. Several other analysts also recently weighed in on the company. Cantor Fitzgerald reiterated an “overweight” […]
